Lantern Pharma Inc (LTRN)
6.88
+0.73
(+11.87%)
USD |
NASDAQ |
May 06, 15:35
Lantern Pharma Cash from Operations (Quarterly): -3.385M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.385M |
| September 30, 2023 | -3.612M |
| June 30, 2023 | -3.592M |
| March 31, 2023 | -3.757M |
| December 31, 2022 | -2.669M |
| September 30, 2022 | -4.038M |
| June 30, 2022 | -2.733M |
| March 31, 2022 | -3.328M |
| December 31, 2021 | -2.039M |
| September 30, 2021 | -4.683M |
| Date | Value |
|---|---|
| June 30, 2021 | -1.726M |
| March 31, 2021 | -2.144M |
| December 31, 2020 | -1.568M |
| September 30, 2020 | -2.890M |
| June 30, 2020 | -0.4909M |
| March 31, 2020 | -0.703M |
| December 31, 2019 | -0.7089M |
| September 30, 2019 | -0.5499M |
| June 30, 2019 | -0.4435M |
| March 31, 2019 | -0.4256M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.683M
Minimum
Sep 2021
-0.4435M
Maximum
Jun 2019
-2.372M
Average
-2.669M
Median
Dec 2022
Cash from Operations (Quarterly) Benchmarks
| Eyenovia Inc | -6.322M |
| Cassava Sciences Inc | -22.32M |
| Alpine Immune Sciences Inc | -18.97M |
| Clearside Biomedical Inc | 0.495M |
| Poseida Therapeutics Inc | -28.74M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.2562M |
| Cash from Financing (Quarterly) | -0.50M |
| Free Cash Flow | -14.37M |
| Free Cash Flow Per Share (Quarterly) | -0.314 |
| Free Cash Flow Yield | -19.26% |